Record NNP B-NP O
date NN I-NP O
: : O O
2068-07-06 CD O B-DATE
Dialysis NNP B-NP O
Fellow NNP I-NP O
Consult NNP I-NP O
Note NN I-NP O
Date NNP B-NP O
of IN B-PP O
Admission NNP B-NP O
: : O O
7/6/2068 CD O B-DATE
Team NNP B-NP O
: : O O
Internal NNP B-NP O
Medicine NNP I-NP O
Fellow NNP B-NP O
: : O O
Wise NNP O B-DOCTOR
Renal NNP B-NP O
Attending NNP I-NP O
: : O O
Leonard NN B-NP B-DOCTOR
Reason NN B-NP O
for IN B-PP O
Consult NNP B-NP O
: : O O
HD NNP B-NP O
needs VBZ B-VP O
while IN B-SBAR O
inpt NN B-NP O
HPI NNP B-NP O
: : O O
48 CD B-NP B-AGE
Spanish JJ I-NP O
speaking NN I-NP O
M NNP I-NP O
( -LRB- I-NP O
interviewed VBD B-VP O
with IN B-PP O
assistance NN B-NP O
of IN B-PP O
interpreter NN B-NP O
services NNS I-NP O
staff NN I-NP O
) -RRB- I-NP O
w/ESKD NN I-NP O
on IN B-PP O
HD NNP B-NP O
2/2 CD I-NP O
T2DM NNP I-NP O
( -LRB- I-NP O
nephrop NN I-NP O
, , O O
retinop NN B-NP O
, , O O
bilat JJ B-NP O
TMA NNP I-NP O
) -RRB- I-NP O
, , I-NP O
HTN NNP I-NP O
, , I-NP O
admitted VBD B-VP O
for IN B-PP O
LLQ NNP B-NP O
pain NN I-NP O
. . O O
Patient NNP B-NP O
recenlty NN I-NP O
admitted VBD B-VP O
to TO I-VP O
PROMPTCARE VB I-VP B-HOSPITAL
for IN B-PP O
refractory JJ B-NP O
constipation NN I-NP O
with IN B-PP O
discharge NN B-NP O
7/01 CD I-NP B-DATE
. . O O
During IN B-PP O
the DT B-NP O
admission NN I-NP O
he PRP B-NP O
was VBD B-VP O
noted VBN I-VP O
to TO I-VP O
have VB I-VP O
inadequate JJ B-NP O
HD NNP I-NP O
and CC I-NP O
underwent JJ I-NP O
AVF NN I-NP O
fistulogram NN I-NP O
and CC O O
subsequent JJ B-NP O
dilation NN I-NP O
of IN B-PP O
stensosis NN B-NP O
. . O O
The DT B-NP O
patient NN I-NP O
attended VBD B-VP O
his PRP$ B-NP O
outpatient NN I-NP O
HD NNP B-NP O
on IN B-PP O
Fri NNP B-NP B-DATE
and CC I-NP O
Sun NNP I-NP B-DATE
. . O O
He PRP B-NP O
developed VBD B-VP O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
back RB B-ADVP O
pain NN B-NP O
and CC I-NP O
difficulty NN I-NP O
breathing NN I-NP O
on IN B-PP O
morning NN B-NP O
of IN B-PP O
admission NN B-NP O
he PRP B-NP O
called VBD B-VP O
EMS NNP B-NP O
and CC O O
was VBD B-VP O
found VBN I-VP O
to TO I-VP O
be VB I-VP O
hypertension NN B-NP O
with IN B-PP O
BP NNP B-NP O
&gt NNP I-NP O
;240/110mmHg NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
given VBN I-VP O
SL NNP B-NP O
nitroglycerine NN I-NP O
with IN B-PP O
relief NN B-NP O
of IN B-PP O
symptoms NNS B-NP O
but CC O O
not RB O O
of IN B-PP O
hypertension NN B-NP O
. . O O
He PRP B-NP O
continued VBD B-VP O
to TO I-VP O
have VB I-VP O
HTN NNP B-NP O
in IN B-PP O
ED NNP B-NP O
and CC O O
underwent IN B-PP O
a DT B-NP O
CT NNP I-NP O
angiogram NN I-NP O
whihc WDT B-NP O
did VBD B-VP O
not RB I-VP O
reveal VB I-VP O
dissection NN B-NP O
only RB B-ADVP O
bilateral JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
. . B-PP O
His PRP$ B-NP O
Trop NNP I-NP O
-T NNP I-NP O
was VBD B-VP O
0.1 CD B-NP O
and CC I-NP O
ECG NNP I-NP O
faied VBD B-VP O
to TO I-VP O
shw VB I-VP O
ischemia NN B-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
admitted VBN I-VP O
for IN B-PP O
managment NN B-NP O
of IN B-PP O
Hypertensive NNP B-NP O
urgency NN I-NP O
ROS NNP B-NP O
: : O O
Full JJ B-NP O
review NN I-NP O
of IN B-PP O
12 CD B-NP O
point NN I-NP O
ROS NNP I-NP O
negative JJ I-NP O
other JJ I-NP O
than IN B-PP O
abnormalities NNS B-NP O
noted VBN B-VP O
in IN B-PP O
HPI. NNP B-NP O
PMHx NNP B-NP O
: : O O
DM NNP B-NP O
, , O O
diagnosed VBD B-VP O
20 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
complicated VBN B-VP O
by IN B-PP O
retinopathy JJ B-NP O
5 CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
nephropathy RB B-NP O
5 CD I-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
and CC O O
bilateral JJ B-NP O
TMA NNP I-NP O
8 CD I-NP O
years NNS I-NP O
ago IN O O
ESRD NNP B-NP O
on IN B-PP O
HD NNP B-NP O
, , O O
started VBD B-VP O
HD NNP B-NP O
5 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
on IN B-PP O
M NNP B-NP B-DATE
W NNP I-NP B-DATE
F NNP I-NP B-DATE
schedule NN I-NP O
at IN B-PP O
Cochran NNP B-NP B-HOSPITAL
Memorial NNP I-NP I-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
Bilateral NNP B-NP O
blindness NN I-NP O
, , O O
started VBD B-VP O
5 CD B-NP O
years NNS I-NP O
ago RB O O
Hypertension NN B-NP O
Hyperlipidemia NNP B-NP O
DepressionGERD/Gastritis NN B-NP O
s/p NN B-NP O
bilateral JJ I-NP O
TMA NNP I-NP O
8 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
complicated VBN B-VP O
by IN B-PP O
osteomyelitis NN B-NP O
of IN B-PP O
right JJ B-NP O
foot NN I-NP O
in IN B-PP O
2065 CD B-NP B-DATE
and CC I-NP O
2068 CD I-NP B-DATE
s/p NN B-NP O
cholecystectomy NN I-NP O
Meds NNS B-NP O
: : O O
per IN B-PP O
recent JJ B-NP O
d/c NN I-NP O
summary NN I-NP O
. . O O
1 LS O O
. . B-NP O
Aspirin NNP I-NP O
81 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
. . O O
2. . B-NP O
Amlodipine NNP I-NP O
10 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
. . O O
3. CD B-NP O
Cinacalcet NNP I-NP O
30 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
at IN B-PP O
bedtime NN B-NP O
. . O O
4 CD B-LST O
. . O O
Clonidine NNP B-NP O
0.2 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
b.i.d '' O O
. . O O
5 CD B-NP O
. . O O
Diphenhydramine NNP B-NP O
oral JJ I-NP O
25 CD I-NP O
mg JJ I-NP O
p.o NN I-NP O
. . O O
3 CD B-NP O
times NNS I-NP O
a DT B-NP O
week NN I-NP O
, , O O
Monday NNP B-NP B-DATE
, , O O
Wednesday NNP B-NP B-DATE
, , O O
Friday NNP B-NP B-DATE
. . O O
6 CD B-NP O
. . O O
Docusate NNP B-NP O
sodium NN I-NP O
100 CD B-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
b.i.d '' O O
. . O O
7. . B-NP O
Duloxetine NNP I-NP O
20 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
b.i.d '' O O
. . O O
8. DT B-NP O
Insulin NNP I-NP O
Lispro NNP I-NP O
mix NN I-NP O
75/25 CD B-NP O
12 CD I-NP O
units NNS I-NP O
subcutaneous JJ B-NP O
every DT I-NP O
night NN I-NP O
. . O O
9 CD B-NP O
. . O O
Insulin NNP B-NP O
Lispro NNP I-NP O
mix NN I-NP O
75/25 CD B-NP O
25 CD I-NP O
units NNS I-NP O
subcutaneous JJ B-ADJP O
before IN B-PP O
meals NNS B-NP O
. . O O
10 CD B-NP O
. . O O
Lisinopril NNP B-NP O
40 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
. . O O
11 CD B-NP O
. . O O
Reglan NNP B-NP O
5 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
q.i.d '' O O
. . O O
12 CD B-NP O
. . O O
Metoprolol NNP B-NP O
succinate JJ I-NP O
extended VBD I-NP O
release NN I-NP O
150 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
daily RB B-ADVP O
. . O O
13 CD B-NP O
. . O O
MiraLax NNP B-NP O
17 CD I-NP O
grams NNS I-NP O
2 CD B-NP O
caps NNS I-NP O
a DT B-NP O
day NN I-NP O
titrate NN I-NP O
to TO B-VP O
bowel VB I-VP O
movement NN B-NP O
. . O O
14 CD B-NP O
. . O O
Senna NNP B-NP O
17.2 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
b.i.d '' O O
. . O O
15 CD B-NP O
. . O O
Sevelamer NNP B-NP O
2400 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . O O
t.i.d '' O O
. . O O
16 CD B-NP O
. . O O
Simvastatin NNP B-NP O
20 CD I-NP O
mg NN I-NP O
p.o NN I-NP O
. . B-NP O
bedtime NN I-NP O
. . O O
17 CD B-NP O
. . O O
Sodium NNP B-NP O
polystyrene NN I-NP O
sulfonate NN I-NP O
15 CD B-NP O
grams NNS I-NP O
p.o RB B-ADVP O
. . O O
4 CD B-NP O
times NNS I-NP O
a DT B-NP O
week NN I-NP O
, , O O
Monday NNP B-NP B-DATE
, , O O
Wednesday NNP B-NP B-DATE
, , O O
Friday NNP B-NP B-DATE
, , O O
Sunday NNP B-NP B-DATE
. . O O
Allerg NNP B-NP O
: : O O
NKDA NNP B-NP O
FHx NNP B-NP O
: : O O
DM . O O
SHx NNP B-NP O
: : O O
( -LRB- B-NP O
per IN B-PP O
note NN B-NP O
from IN B-PP O
previous JJ B-NP O
admission NN I-NP O
3/10/68 . O B-DATE
) -RRB- O O
Originally RB B-ADVP O
from IN B-PP O
Panama NNP B-NP B-CITY
City NNP I-NP I-CITY
. . O O
Lives NNS B-VP O
with IN B-PP O
his PRP$ B-NP O
mother NN I-NP O
in IN B-PP O
Needville NNP B-NP B-CITY
. . O O
Never RB B-VP O
married VBN I-VP O
, , O O
no DT B-NP O
children NNS I-NP O
. . O O
Tobacco NNP B-NP O
: : O O
Quit VB B-VP O
8 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
used VBD B-VP O
to TO I-VP O
smoke VB I-VP O
1/2 CD B-NP O
PPD NNP I-NP O
EtOH NNP B-NP O
: : O O
Quit VB B-VP O
8 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
, , O O
used VBD B-VP O
to TO I-VP O
be VB I-VP O
a DT B-NP O
heavy JJ I-NP O
drinker NN I-NP O
Illicits NNS B-NP O
: : O O
Never RB O O
P/E NNP B-NP O
: : O O
Vitals NNS B-NP O
Temp NNP I-NP O
98. CD I-NP O
HR NNP B-NP O
74 CD I-NP O
, , O O
BP NNP B-NP O
160/70 CD I-NP O
, , O O
RR NNP B-NP O
18 CD I-NP O
, , O O
SaO2 NNP B-NP O
97 CD I-NP O
% NN I-NP O
on IN B-PP O
2L JJ B-NP O
n/c NN I-NP O
General NNP B-NP O
: : O O
Obese NNP B-NP O
male NN I-NP O
, , O O
mildly RB B-NP O
somnolent NN I-NP O
HEENT NNP B-NP O
: : O O
Thick JJ B-NP O
neck NN I-NP O
, , O O
JVP NNP B-NP O
6cm JJ I-NP O
, , I-NP O
moist JJ I-NP O
mucosa NN I-NP O
RESP NNP B-NP O
: : O O
Diminished NNP B-NP O
breath NN I-NP O
sounds VBZ B-VP O
at IN B-SBAR O
bases NNS B-NP O
Left VBD B-VP O
&gt PRP B-NP O
; : O O
Right RB O O
CVS NNP B-NP O
: : O O
HS1-2 CD B-NP O
, , O O
RRR NNP B-NP O
, , O O
no DT B-NP O
gallops NNS I-NP O
or CC I-NP O
murmus NN I-NP O
Abdo NNP B-NP O
: : O O
No DT B-NP O
distention NN I-NP O
or CC I-NP O
tenderness NN I-NP O
. . O O
Ext JJ B-NP O
: : O O
AVF NN B-NP O
on IN B-PP O
Left NNP B-NP O
forearm IN B-PP O
bounding VBG B-VP O
pulse NN B-NP O
, , O O
minimal JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
Neuro NNP B-NP O
: : O O
able JJ B-ADJP O
to TO B-VP O
move VB I-VP O
all DT B-NP O
4 CD I-NP O
extremites NNS I-NP O
Pysch NNP B-NP O
: : O O
No DT B-NP O
abnormal JJ I-NP O
affect VB B-VP O
noted VBN I-VP O
Labs NNS B-NP O
predialysis NN I-NP O
Na NNP B-NP O
136 CD I-NP O
, , O O
K NNP B-NP O
5.4 CD I-NP O
, , O O
Cl NNP B-NP O
95 CD I-NP O
, , O O
HCO3 CC O O
23 CD B-NP O
, , O O
BUN NNP B-NP O
42 CD I-NP O
, , O O
Cr NNP B-NP O
9.39 CD I-NP O
Ca JJ B-NP O
11.2 CD I-NP O
, , O O
PO4 NNP B-NP O
2.8 CD I-NP O
, , O O
PTH NNP B-NP O
1112 CD I-NP O
Hg NNP B-NP O
11 CD I-NP O
, , O O
Fe NNP B-NP O
23 CD I-NP O
, , O O
Ferrtin NNP B-NP O
1336 CD I-NP O
, , O O
TIBC NNP B-NP O
121 CD I-NP O
ECG NNP B-NP O
: : O O
SR NNP B-NP O
, , O O
LVH NNP B-NP O
, , O O
no DT B-NP O
ischemia NN I-NP O
. . O O
A/P . O O
48 CD B-NP B-AGE
M NNP I-NP O
with IN B-PP O
ESRD NNP B-NP O
presents NNS I-NP O
in IN B-PP O
Hypertensive NNP B-NP O
emergency NN I-NP O
, , O O
concern NN B-NP O
for IN B-PP O
medical JJ B-NP O
noncompliance NN I-NP O
with IN B-PP O
possible JJ B-NP O
volume NN I-NP O
overlod JJ B-PP O
as IN I-PP O
etiology NN B-NP O
though IN I-NP O
appears VBZ B-VP O
by IN B-PP O
record NN B-NP O
to TO B-VP O
attend VB I-VP O
HD NNP B-NP O
though IN B-PP O
elevated VBN B-NP O
Cr NNP I-NP O
perhaps RB B-ADVP O
suggest VBP B-VP O
inadequate JJ B-NP O
HD. NNP I-NP O
Alos NNP I-NP O
possible JJ I-NP O
is VBZ B-VP O
non-compliance JJ B-ADJP O
with IN B-PP O
volume NN B-NP O
restriction NN I-NP O
and CC O O
marked VBD B-VP O
intra-dialytic JJ B-NP O
wieght NN I-NP O
gain NN I-NP O
as IN B-PP O
cause NN B-NP O
of IN B-PP O
today NN B-NP O
' POS B-NP O
presentation NN I-NP O
. . O O
Plan NN B-NP O
ESRD NNP B-NP O
HD NNP B-NP O
today NN I-NP O
4hrs NNS B-NP O
, , O O
UF NNP B-NP O
3kg CD I-NP O
, , O O
Bath NNP B-NP O
Na NNP I-NP O
140 CD I-NP O
, , O O
K NNP B-NP O
2.0, VBD B-VP O
Ca JJ B-NP O
2.5 CD I-NP O
, , O O
HCO3 NNP B-NP O
25 CD I-NP O
Anemia NNP B-NP O
: : O O
Hg NNP B-NP O
11 CD I-NP O
, , O O
Ferritin NNP B-NP O
1336 CD I-NP O
, , O O
no DT B-NP O
Fe NNP I-NP O
supplementation NN I-NP O
avoid VB B-VP O
EPO NNP B-NP O
while IN B-SBAR O
HTN NNP B-NP O
urgency NN I-NP O
Metabolic NNP B-NP O
bone NN I-NP O
disease NN I-NP O
: : O O
PTH NNP B-NP O
1112 CD I-NP O
, , O O
Ca MD B-VP O
11.3 VB I-VP O
on IN B-PP O
paricalcitrol NN B-NP O
at IN B-PP O
HD NNP B-NP O
continue VB B-VP O
sevelamer JJ B-NP O
AC NNP I-NP O
HTN NNP B-NP O
: : O O
Will MD B-NP O
attempt VB B-VP O
agressive JJ B-NP O
UF NNS I-NP O
while IN B-SBAR O
inpatient NN B-NP O
to TO B-VP O
reduce VB I-VP O
EDW NNP B-NP O
, , O O
continue VBP B-VP O
medical JJ B-NP O
managment NN I-NP O
as IN B-PP O
reduced VBN B-NP O
EDW NNP I-NP O
is VBZ B-VP O
attempted VBN I-VP O
. . O O
Access NNP B-NP O
: : O O
AVF NN B-NP O
with IN B-PP O
recent JJ B-NP O
fistuloplasty JJ I-NP O
good JJ I-NP O
flows NNS I-NP O
achieved VBD B-VP O
at IN B-PP O
HD NNP B-NP O
Case NNP B-NP O
discussed VBD B-VP O
with IN B-PP O
Dr NNP B-NP O
N NNP I-NP B-DOCTOR
Leonard NN I-NP I-DOCTOR
Howard NNP B-NP B-DOCTOR
Wise NNP I-NP I-DOCTOR
MD NNP I-NP O
39607 CD O B-PHONE
EDUCARE-FARGO NNP B-NP B-HOSPITAL
Renal NNP I-NP O
Fellow NNP I-NP O
